Community Mental Health Affiliates is a licensed substance use treatment provider in New Britain, CT, listed in the SAMHSA treatment directory. Outpatient care is offered, so clients can keep living at home between scheduled sessions. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting HUSKY Health. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adultsTreatment for co-occurring disorders plus serious emotional disturbance (SED) in children
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidPrivate health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State mental health departmentState department of healthThe Joint Commission
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare